A Nomogram for Predicting Vision-Threatening Diabetic Retinopathy Among Mild Diabetic Retinopathy Patients: A Case–Control and Prospective Study of Type 2 Diabetes

References

• Sabanayagam C, Chee ML, Banu R, et al. Association of diabetic retinopathy and diabetic kidney disease with all-cause and cardiovascular mortality in a multiethnic asian population. JAMA Netw Open. 2019;2(3):e191540. doi:10.1001/jamanetworkopen.2019.1540
   PubMed Web of Science ®Google Scholar
• Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376(9735):124–136. doi:10.1016/S0140-6736(09)62124-3
   PubMed Web of Science ®Google Scholar
• Monaco WA, Crews JE, Nguyen ATH, Arif A. Prevalence of vision loss and associations with age-related eye diseases among nursing home residents aged ≥65 years. J Am Med Dir Assoc. 2020;22:1156–1161. doi:10.1016/j.jamda.2020.08.036
   PubMed Web of Science ®Google Scholar
• Vujosevic S, Aldington SJ, Silva P, et al. Screening for diabetic retinopathy: new perspectives and challenges. Lancet Diabetes Endocrinol. 2020;8(4):337–347. doi:10.1016/S2213-8587(19)30411-5
   PubMed Web of Science ®Google Scholar
• Teo ZL, Tham YC, Yu M, et al. Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis. Ophthalmology. 2021;128(11):1580–1591. doi:10.1016/j.ophtha.2021.04.027
   PubMed Web of Science ®Google Scholar
• Broadbent DM, Wang A, Cheyne CP, et al. Safety and cost-effectiveness of individualised screening for diabetic retinopathy: the ISDR open-label, equivalence RCT. Diabetologia. 2021;64(1):56–69. doi:10.1007/s00125-020-05313-2
   PubMed Web of Science ®Google Scholar
• Larsen MB, Henriksen JE, Grauslund J, Peto T. Prevalence and risk factors for diabetic retinopathy in 17 152 patients from the island of Funen, Denmark. Acta Ophthalmol. 2017;95(8):778–786. doi:10.1111/aos.13449
   PubMed Web of Science ®Google Scholar
• Tyrberg M, Nyström L, Arnqvist HJ, et al. Overweight, hyperglycemia and tobacco use are modifiable risk factors for onset of retinopathy 9 and 17 years after the diagnosis of diabetes - A retrospective observational nation-wide cohort study. Diabetes Res Clin Pract. 2017;133:21–29. doi:10.1016/j.diabres.2017.08.009
   PubMed Web of Science ®Google Scholar
• Bebu I, Braffett BH, Schade D, et al. An observational study of the equivalence of age and duration of diabetes to glycemic control relative to the risk of complications in the combined cohorts of the DCCT/EDIC study. Diabetes Care. 2020;43(10):2478–2484. doi:10.2337/dc20-0226
   PubMed Web of Science ®Google Scholar
• Kumari N, Bhargava M, Nguyen DQ, et al. Six-year incidence and progression of diabetic retinopathy in Indian adults: the Singapore Indian Eye study. Br J Ophthalmol. 2019;103(12):1732–1739. doi:10.1136/bjophthalmol-2018-313282
   PubMed Web of Science ®Google Scholar
• Kang EY, Lo FS, Wang JP, et al. Nomogram for prediction of non-proliferative diabetic retinopathy in juvenile-onset type 1 diabetes: a cohort study in an Asian population. Sci Rep. 2018;8(1):12164. doi:10.1038/s41598-018-30521-7
   PubMedGoogle Scholar
• Chew EY, Davis MD, Danis RP, et al. The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the action to control cardiovascular risk in diabetes (ACCORD) eye study. Ophthalmology. 2014;121(12):2443–2451. doi:10.1016/j.ophtha.2014.07.019
   PubMed Web of Science ®Google Scholar
• Bhatwadekar AD, Shughoury A, Belamkar A, Ciulla TA. Genetics of diabetic retinopathy, a leading cause of irreversible blindness in the industrialized world. Genes. 2021;12:8. doi:10.3390/genes12081200
   Web of Science ®Google Scholar
• Milluzzo A, Maugeri A, Barchitta M, Sciacca L, Agodi A. Epigenetic mechanisms in type 2 diabetes retinopathy: a systematic review. Int J Mol Sci. 2021;22:19. doi:10.3390/ijms221910502
   Web of Science ®Google Scholar
• Milluzzo A, Barchitta M, Maugeri A, et al. Do nutrients and nutraceuticals play a role in diabetic retinopathy? A systematic review. Nutrients. 2022;14:20. doi:10.3390/nu14204430
   Web of Science ®Google Scholar
• Li L, Yang Y, Zhu X, et al. Design and validation of a scoring model for differential diagnosis of diabetic nephropathy and nondiabetic renal diseases in type 2 diabetic patients. J Diabetes. 2020;12(3):237–246. doi:10.1111/1753-0407.12994
   PubMed Web of Science ®Google Scholar
• Yao L, Zhong Y, Wu J, et al. Multivariable logistic regression and back propagation artificial neural network to predict diabetic retinopathy. Diabetes Metab Syndr Obes. 2019;12:1943–1951. doi:10.2147/DMSO.S219842
   PubMed Web of Science ®Google Scholar
• Wilkinson CP, Ferris FL 3rd, Klein RE, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110(9):1677–1682. doi:10.1016/S0161-6420(03)00475-5
   PubMed Web of Science ®Google Scholar
• Sauerbrei W, Royston P, Binder H. Selection of important variables and determination of functional form for continuous predictors in multivariable model building. Stat Med. 2007;26(30):5512–5528. doi:10.1002/sim.3148
   PubMed Web of Science ®Google Scholar
• Ganjifrockwala FA, Joseph JT, George G. Evaluation of kidney function and risk factors of retinopathy in type 2 diabetes mellitus people in South Africa. Diabetes Res Clin Pract. 2017;127:218–223. doi:10.1016/j.diabres.2017.03.022
   PubMed Web of Science ®Google Scholar
• Zhuang X, Cao D, Zeng Y, et al. Associations between retinal microvasculature/microstructure and renal function in type 2 diabetes patients with early chronic kidney disease. Diabetes Res Clin Pract. 2020;168:108373. doi:10.1016/j.diabres.2020.108373
   PubMed Web of Science ®Google Scholar
• Romero-Aroca P, Navarro-Gil R, Valls-Mateu A, Sagarra-Alamo R, Moreno-Ribas A, Soler N. Differences in incidence of diabetic retinopathy between type 1 and 2 diabetes mellitus: a nine-year follow-up study. Br J Ophthalmol. 2017;101(10):1346–1351. doi:10.1136/bjophthalmol-2016-310063
   PubMed Web of Science ®Google Scholar
• Chen YH, Chen HS, Tarng DC. More impact of microalbuminuria on retinopathy than moderately reduced GFR among type 2 diabetic patients. Diabetes Care. 2012;35(4):803–808. doi:10.2337/dc11-1955
   PubMed Web of Science ®Google Scholar
• Wang Y, Wan H, Chen Y, et al. Association of C-peptide with diabetic vascular complications in type 2 diabetes. Diabetes Metab. 2020;46(1):33–40. doi:10.1016/j.diabet.2019.04.004
   PubMed Web of Science ®Google Scholar
• Yoon HJ, Cho YZ, Kim JY, et al. Correlations between glucagon stimulated C-peptide levels and microvascular complications in type 2 diabetes patients. Diabetes Metab J. 2012;36(5):379–387. doi:10.4093/dmj.2012.36.5.379
   PubMedGoogle Scholar
• Kimura H, Harada N, Suzuki S, Takeuchi T. Sensory axonal dysfunction in the upper and lower limb of diabetic patients and its relation to diabetic retinopathy. Diabetes Res. 1987;4(4):169–173.
   PubMedGoogle Scholar
• Saini DC, Kochar A, Poonia R. Clinical correlation of diabetic retinopathy with nephropathy and neuropathy. Indian J Ophthalmol. 2021;69(11):3364–3368. doi:10.4103/ijo.IJO_1237_21
   PubMed Web of Science ®Google Scholar
• Tapp RJ, Shaw JE, Harper CA, et al. The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care. 2003;26(6):1731–1737. doi:10.2337/diacare.26.6.1731
   PubMed Web of Science ®Google Scholar
• Busik JV. Lipid metabolism dysregulation in diabetic retinopathy. J Lipid Res. 2021;62:100017. doi:10.1194/jlr.TR120000981
   PubMed Web of Science ®Google Scholar
• Cheung N, Chee ML, Klein R, et al. Incidence and progression of diabetic retinopathy in a multi-ethnic US cohort: the multi-ethnic study of atherosclerosis. Br J Ophthalmol. 2022;106(9):1264–1268. doi:10.1136/bjophthalmol-2021-318992
   PubMed Web of Science ®Google Scholar
• Gubitosi-Klug R, Libman I, Drews KL, et al. TODAY Study Group. Development and progression of diabetic retinopathy in adolescents and young adults with type 2 diabetes: results from the TODAY Study. Diabetes Care. 2021;45(5):1049–1055.
   PubMed Web of Science ®Google Scholar
• Park JY, Hwang JH, Kang MJ, Sim HE, Kim JS, Ko KS. Effects of glycemic variability on the progression of diabetic retinopathy among patients with type 2 diabetes. Retina. 2021;41(7):1487–1495. doi:10.1097/IAE.0000000000003049
   PubMed Web of Science ®Google Scholar
• Eckel RH, McLean E, Albers JJ, Cheung MC, Bierman EL. Plasma lipids and microangiopathy in insulin-dependent diabetes mellitus. Diabetes Care. 1981;4(4):447–453. doi:10.2337/diacare.4.4.447
   PubMed Web of Science ®Google Scholar
• Lyons TJ, Jenkins AJ, Zheng D, et al. Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort. Invest Ophthalmol Vis Sci. 2004;45(3):910–918. doi:10.1167/iovs.02-0648
   PubMed Web of Science ®Google Scholar
• Zhao Y, Li X, Li S, et al. Using machine learning techniques to develop risk prediction models for the risk of incident diabetic retinopathy among patients with type 2 diabetes mellitus: a cohort study. Front Endocrinol. 2022;13:876559. doi:10.3389/fendo.2022.876559
   PubMed Web of Science ®Google Scholar
• Klein R, Sharrett AR, Klein BE, et al. The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes: the atherosclerosis risk in communities study. Ophthalmology. 2002;109(7):1225–1234. doi:10.1016/S0161-6420(02)01074-6
   PubMed Web of Science ®Google Scholar
• van der Heijden AA, Nijpels G, Badloe F, et al. Prediction models for development of retinopathy in people with type 2 diabetes: systematic review and external validation in a Dutch primary care setting. Diabetologia. 2020;63(6):1110–1119. doi:10.1007/s00125-020-05134-3
   PubMed Web of Science ®Google Scholar